2m 2m 2m 2m 2m 2m 2m
InfuSys Hldgs (INFU)
NYSE
$9.02-$0.010 (-0.11%)
Price as of Jun 03, 2026 4:12 PM EDT- $183.0MMarket Cap
- 48.03%1-Year Change
- Medical DevicesIndustry
InfuSys Hldgs (INFU)
$9.02-$0.010 (-0.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 143.4M +6.36% | 134.9M +7.22% | 125.8M +14.44% | 109.9M +7.36% | |
Cost of Revenue | 63.1M -2.04% | 64.5M +2.84% | 62.7M +32.39% | 47.3M +12.23% | |
Gross Profit | 80.3M +14.05% | 70.4M +11.56% | 63.1M +0.86% | 62.6M +3.94% | |
Sales and Marketing Expense | 10.5M -7.29% | 11.3M -10.61% | 12.7M +3.22% | 12.3M +13.75% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 920,000 -7.16% | 991,000 +0.10% | 990,000 -60.30% | 2.5M -41.48% | |
Total Operating Expenses | 68.4M +7.66% | 63.5M +7.61% | 59.0M -3.11% | 60.9M +6.17% | |
Operating Profit | 11.9M +72.98% | 6.9M +68.57% | 4.1M +147.16% | 1.7M -41.35% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.2M +54.78% | -1.4M +1.82% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -2.2M +54.78% | -1.4M +1.82% | |
Total Nonoperating Income and Expense | 2,000 +103.64% | -55,000 -17.91% | -67,000 -45.08% | -122,000 -34.41% | |
Income before Taxes | 10.6M +109.98% | 5.1M +173.31% | 1.9M +1,323.85% | 130,000 -89.66% | |
Income Taxes | 4.0M +47.24% | 2.7M +177.22% | 979,000 +774.11% | 112,000 +168.71% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 6.6M +182.60% | 2.3M +168.92% | 872,000 +4,744.44% | 18,000 -98.73% | |
Net Income from Continuing Operations Applicable to Common | 10.6M +109.98% | 5.1M +173.31% | 1.9M +1,323.85% | 130,000 -89.66% | |
Basic EPS and Net Income | 0.32 +190.91% | 0.11 +175.00% | 0.04 N/A | 0.00 -100.00% | |
Diluted EPS and Net Income | 0.31 +181.82% | 0.11 +175.00% | 0.04 N/A | 0.00 -100.00% | |
Basic Weighted Average Shares | 20.7M -2.89% | 21.3M +1.18% | 21.0M +1.82% | 20.6M +0.63% | |
Diluted Weighted Average Shares | 21.1M -2.81% | 21.7M +0.28% | 21.6M +0.46% | 21.5M -2.28% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.2M +504.55% | 527,000 +128.14% | 231,000 +40.00% | 165,000 -11.29% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.2M +504.55% | 527,000 +128.14% | 231,000 +40.00% | 165,000 -11.29% | |
Total Current Assets | 36.3M +12.97% | 32.2M +5.05% | 30.6M +23.57% | 24.8M +12.30% | |
Accumulated Depreciation | 5.0M -29.60% | 7.1M +20.20% | 5.9M +21.12% | 4.9M +27.76% | |
Property and Plant and Equipment and Net | 3.4M -16.65% | 4.0M -6.73% | 4.3M -1.46% | 4.4M -3.05% | |
Total Long-Term Assets | 1.7M +91.12% | 878,000 -44.47% | 1.6M +1,876.25% | 80,000 -83.01% | |
Total Assets | 100.6M -2.95% | 103.6M +0.68% | 102.9M +3.55% | 99.4M +1.85% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 20.0M -17.10% | 24.1M -18.05% | 29.4M N/A | 0 -100.00% | |
Total Current Liabilities | 20.2M +14.27% | 17.7M +12.40% | 15.7M +8.61% | 14.5M +12.18% | |
Total Long-Term Debt | 19.6M -17.76% | 23.9M -18.00% | 29.1M -12.23% | 33.2M +1.25% | |
Total Long-Term Liabilities | 23.1M -18.90% | 28.4M -18.56% | 34.9M -5.47% | 36.9M +1.37% | |
Total Liabilities | 43.2M -6.19% | 46.1M -8.95% | 50.6M -1.50% | 51.4M +4.20% | |
Retained Earnings | -60.7M +5.64% | -57.5M -1.99% | -58.6M -1.21% | -59.3M +10.09% | |
Total Stockholders Equity | 57.3M -0.35% | 57.5M +9.99% | 52.3M +8.96% | 48.0M -0.56% | |
Total Shares Outstanding | 20.2M -5.00% | 21.3M +0.36% | 21.2M +2.00% | 20.8M +0.40% | |
Cash Flow | |||||
Cash from Operating Activities | 24.4M +19.30% | 20.5M +82.30% | 11.2M -35.93% | 17.5M -4.36% | |
Capital Expenditures | 560,000 -48.72% | 1.1M +6.64% | 1.0M +4.28% | 982,000 +0.20% | |
Cash from Investing Activities | -6.8M -48.71% | -13.2M +96.60% | -6.7M -41.33% | -11.5M -46.15% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -15.0M +116.05% | -6.9M +56.55% | -4.4M -27.01% | -6.1M -6.24% | |
Financials Ratio | |||||
Gross Margin | 55.98% +7.23% | 52.20% +4.05% | 50.17% -11.87% | 56.93% -3.18% | |
Operating Margin | 8.31% +62.64% | 5.11% +57.22% | 3.25% +115.98% | 1.50% -45.37% | |
Return on Assets | 6.49% +185.86% | 2.27% +163.41% | 0.86% +4,610.93% | 0.02% -98.75% | |
Return on Equity | 11.54% +170.24% | 4.27% +145.60% | 1.74% +4,548.93% | 0.04% -98.83% | |
Revenue Growth | 6.36% -11.88% | 7.22% -50.03% | 14.44% +96.27% | 7.36% +43.47% | |
Current Ratio | 1.80 -1.14% | 1.82 -6.54% | 1.95 +13.77% | 1.71 +0.11% | |
Cash Ratio | 0.16 +429.87% | 0.03 +102.72% | 0.01 +28.95% | 0.01 -20.83% | |
Debt-to-Equity Ratio | 0.69 -17.14% | 0.83 -25.47% | 1.12 +62.05% | 0.69 +0.74% | |
Debt-to-Assets Ratio | 0.39 -14.92% | 0.46 -18.58% | 0.57 +70.50% | 0.33 -1.65% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow